Life is a health journey and we at Sanofi are committed to provide effective medications for people concerned with thrombotic diseases or disorders caused by abnormal blood flow.

Atherothrombosis is the underlying cause of heart attack and stroke. In the Philippines, 276 die from heart attack everyday while one person dies every minute from stroke1. An increase in the number of heart attacks and strokes is expected in the future. Estimates forecast over 20 million deaths in 2020 and over 24 million in 2030. 

Thrombosis is the process of blood clot. The clot forms in the artery or veins and can obstruct flow in affected areas and causes the world’s top three cardiovascular killers: heart attack, stroke, and venous thromboembolism (VTE)- a blood clot that is found mostly in the leg and lungs. Thrombotic diseases, with their venous and arterial repercussions, are now one of the world’s leading causes of mortality.

Based on the Assessment of the Incidence of Deep vein thrombosis in Asia (AIDA) study, DVT is a common complication among Asians who underwent major orthopedic surgery of the lower limbs.

Also, according to the Philippine Council for Health Research and Development, several factors can increase one’s risk for DVT, including certain cancers, advanced age, long periods of sitting or bedrest, and obesity2.

As a health journey partner, we are dedicated to offer treatments targeted for the prevention and management of thrombosis so that patients who are afflicted with this condition can have a quality life.

The diseases targeted by Sanofi:

Deep Venous Thrombosis, Complicated or Not by Pulmonary Embolism
Acute Coronary Syndromes (Angina, Myocardial Infarction)

1 (Accessed June 1, 2018)
2 Philippine Council for Health Research and Development. “Deep vein thrombosis: You’re so vein”. Philippine Council for Health Research and Development. N.d. news/1396-deep-vein-thrombosis-youre-so-vein. (Accessed May 25, 2018)